[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Swine Vaccines Market in Japan - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 102 pages | ID: S2B3234E7246EN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
This report contains market size and forecasts of Swine Vaccines in Japan, including the following market information:
Japan Swine Vaccines Market Revenue, 2015-2020, 2021-2026, ($ millions)
Japan Swine Vaccines Market Consumption, 2015-2020, 2021-2026, (M Doses)
Japan Swine Vaccines Production Capacity, 2015-2020, 2021-2026, (M Doses)
Top Five Competitors in Japan Swine Vaccines Market 2019 (%)
The global Swine Vaccines market was valued at 1314.6 million in 2019 and is projected to reach US$ 1527.7 million by 2026, at a CAGR of 3.8% during the forecast period. While the Swine Vaccines market size in Japan was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Swine Vaccines manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Swine Vaccines production and consumption in Japan

Total Market by Segment:

Japan Swine Vaccines Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Doses)
Japan Swine Vaccines Market Segment Percentages, By Type, 2019 (%)
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Other
Japan Swine Vaccines Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Doses)
Japan Swine Vaccines Market Segment Percentages, By Application, 2019 (%)
  • Government Tender
  • Market Sales
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Swine Vaccines Market Competitors Revenues in Japan, by Players 2015-2020 (Estimated), ($ millions)
Total Swine Vaccines Market Competitors Revenues Share in Japan, by Players 2019 (%)
Total Japan Swine Vaccines Market Competitors Sales, by Players 2015-2020 (Estimated), (M Doses)
Total Japan Swine Vaccines Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Merck
  • Boehringer Ingelheim
  • Jinyu Bio-Technology
  • CAHIC
  • Tecon
  • Zoetis
  • Ceva
  • Hile Bio
  • Chopper Biology
  • WINSUN
  • Hipra
  • Ringpu Biology
  • ChengDu Tecbond
  • DHN
  • CAVAC
  • Virbac
  • HVRI
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Swine Vaccines Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Japan Swine Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: JAPAN SWINE VACCINES OVERALL MARKET SIZE

2.1 Japan Swine Vaccines Market Size: 2020 VS 2026
2.2 Japan Swine Vaccines Revenue, Prospects & Forecasts: 2015-2026
2.3 Japan Swine Vaccines Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Swine Vaccines Players in Japan (including Foreign and Local Companies)
3.2 Top Japan Swine Vaccines Companies Ranked by Revenue
3.3 Japan Swine Vaccines Revenue by Companies (including Foreign and Local Companies)
3.4 Japan Swine Vaccines Sales by Companies (including Foreign and Local Companies)
3.5 Japan Swine Vaccines Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Swine Vaccines Companies in Japan, by Revenue in 2019
3.7 Japan Manufacturers Swine Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Swine Vaccines Players in Japan
  3.8.1 List of Japan Tier 1 Swine Vaccines Companies
  3.8.2 List of Japan Tier 2 and Tier 3 Swine Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Japan Swine Vaccines Market Size Markets, 2020 & 2026
  4.1.2 CSF Vaccines
  4.1.3 FMD Vaccines
  4.1.4 Porcine Circovirus Vaccines
  4.1.5 PRRS Vaccines
  4.1.6 Other
4.2 By Type - Japan Swine Vaccines Revenue & Forecasts
  4.2.1 By Type - Japan Swine Vaccines Revenue, 2015-2020
  4.2.2 By Type - Japan Swine Vaccines Revenue, 2021-2026
  4.2.3 By Type - Japan Swine Vaccines Revenue Market Share, 2015-2026
4.3 By Type - Japan Swine Vaccines Sales & Forecasts
  4.3.1 By Type - Japan Swine Vaccines Sales, 2015-2020
  4.3.2 By Type - Japan Swine Vaccines Sales, 2021-2026
  4.3.3 By Type - Japan Swine Vaccines Sales Market Share, 2015-2026
4.4 By Type - Japan Swine Vaccines Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Japan Swine Vaccines Market Size, 2020 & 2026
  5.1.2 Government Tender
  5.1.3 Market Sales
5.2 By Application - Japan Swine Vaccines Revenue & Forecasts
  5.2.1 By Application - Japan Swine Vaccines Revenue, 2015-2020
  5.2.2 By Application - Japan Swine Vaccines Revenue, 2021-2026
  5.2.3 By Application - Japan Swine Vaccines Revenue Market Share, 2015-2026
5.3 By Application - Japan Swine Vaccines Sales & Forecasts
  5.3.1 By Application - Japan Swine Vaccines Sales, 2015-2020
  5.3.2 By Application - Japan Swine Vaccines Sales, 2021-2026
  5.3.3 By Application - Japan Swine Vaccines Sales Market Share, 2015-2026
5.4 By Application - Japan Swine Vaccines Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Merck
  6.1.1 Merck Corporate Summary
  6.1.2 Merck Business Overview
  6.1.3 Merck Swine Vaccines Major Product Offerings
  6.1.4 Merck Sales and Revenue in Japan (2015-2020)
  6.1.5 Merck Key News
6.2 Boehringer Ingelheim
  6.2.1 Boehringer Ingelheim Corporate Summary
  6.2.2 Boehringer Ingelheim Business Overview
  6.2.3 Boehringer Ingelheim Swine Vaccines Major Product Offerings
  6.2.4 Boehringer Ingelheim Sales and Revenue in Japan (2015-2020)
  6.2.5 Boehringer Ingelheim Key News
6.3 Jinyu Bio-Technology
  6.3.1 Jinyu Bio-Technology Corporate Summary
  6.3.2 Jinyu Bio-Technology Business Overview
  6.3.3 Jinyu Bio-Technology Swine Vaccines Major Product Offerings
  6.3.4 Jinyu Bio-Technology Sales and Revenue in Japan (2015-2020)
  6.3.5 Jinyu Bio-Technology Key News
6.4 CAHIC
  6.4.1 CAHIC Corporate Summary
  6.4.2 CAHIC Business Overview
  6.4.3 CAHIC Swine Vaccines Major Product Offerings
  6.4.4 CAHIC Sales and Revenue in Japan (2015-2020)
  6.4.5 CAHIC Key News
6.5 Tecon
  6.5.1 Tecon Corporate Summary
  6.5.2 Tecon Business Overview
  6.5.3 Tecon Swine Vaccines Major Product Offerings
  6.5.4 Tecon Sales and Revenue in Japan (2015-2020)
  6.5.5 Tecon Key News
6.6 Zoetis
  6.6.1 Zoetis Corporate Summary
  6.6.2 Zoetis Business Overview
  6.6.3 Zoetis Swine Vaccines Major Product Offerings
  6.6.4 Zoetis Sales and Revenue in Japan (2015-2020)
  6.6.5 Zoetis Key News
6.7 Ceva
  6.6.1 Ceva Corporate Summary
  6.6.2 Ceva Business Overview
  6.6.3 Ceva Swine Vaccines Major Product Offerings
  6.4.4 Ceva Sales and Revenue in Japan (2015-2020)
  6.7.5 Ceva Key News
6.8 Hile Bio
  6.8.1 Hile Bio Corporate Summary
  6.8.2 Hile Bio Business Overview
  6.8.3 Hile Bio Swine Vaccines Major Product Offerings
  6.8.4 Hile Bio Sales and Revenue in Japan (2015-2020)
  6.8.5 Hile Bio Key News
6.9 Chopper Biology
  6.9.1 Chopper Biology Corporate Summary
  6.9.2 Chopper Biology Business Overview
  6.9.3 Chopper Biology Swine Vaccines Major Product Offerings
  6.9.4 Chopper Biology Sales and Revenue in Japan (2015-2020)
  6.9.5 Chopper Biology Key News
6.10 WINSUN
  6.10.1 WINSUN Corporate Summary
  6.10.2 WINSUN Business Overview
  6.10.3 WINSUN Swine Vaccines Major Product Offerings
  6.10.4 WINSUN Sales and Revenue in Japan (2015-2020)
  6.10.5 WINSUN Key News
6.11 Hipra
  6.11.1 Hipra Corporate Summary
  6.11.2 Hipra Swine Vaccines Business Overview
  6.11.3 Hipra Swine Vaccines Major Product Offerings
  6.11.4 Hipra Sales and Revenue in Japan (2015-2020)
  6.11.5 Hipra Key News
6.12 Ringpu Biology
  6.12.1 Ringpu Biology Corporate Summary
  6.12.2 Ringpu Biology Swine Vaccines Business Overview
  6.12.3 Ringpu Biology Swine Vaccines Major Product Offerings
  6.12.4 Ringpu Biology Sales and Revenue in Japan (2015-2020)
  6.12.5 Ringpu Biology Key News
6.13 ChengDu Tecbond
  6.13.1 ChengDu Tecbond Corporate Summary
  6.13.2 ChengDu Tecbond Swine Vaccines Business Overview
  6.13.3 ChengDu Tecbond Swine Vaccines Major Product Offerings
  6.13.4 ChengDu Tecbond Sales and Revenue in Japan (2015-2020)
  6.13.5 ChengDu Tecbond Key News
6.14 DHN
  6.14.1 DHN Corporate Summary
  6.14.2 DHN Swine Vaccines Business Overview
  6.14.3 DHN Swine Vaccines Major Product Offerings
  6.14.4 DHN Sales and Revenue in Japan (2015-2020)
  6.14.5 DHN Key News
6.15 CAVAC
  6.15.1 CAVAC Corporate Summary
  6.15.2 CAVAC Swine Vaccines Business Overview
  6.15.3 CAVAC Swine Vaccines Major Product Offerings
  6.15.4 CAVAC Sales and Revenue in Japan (2015-2020)
  6.15.5 CAVAC Key News
6.16 Virbac
  6.16.1 Virbac Corporate Summary
  6.16.2 Virbac Swine Vaccines Business Overview
  6.16.3 Virbac Swine Vaccines Major Product Offerings
  6.16.4 Virbac Sales and Revenue in Japan (2015-2020)
  6.16.5 Virbac Key News
6.17 HVRI
  6.17.1 HVRI Corporate Summary
  6.17.2 HVRI Swine Vaccines Business Overview
  6.17.3 HVRI Swine Vaccines Major Product Offerings
  6.17.4 HVRI Sales and Revenue in Japan (2015-2020)
  6.17.5 HVRI Key News
6.18 Bioveta
  6.18.1 Bioveta Corporate Summary
  6.18.2 Bioveta Swine Vaccines Business Overview
  6.18.3 Bioveta Swine Vaccines Major Product Offerings
  6.18.4 Bioveta Sales and Revenue in Japan (2015-2020)
  6.18.5 Bioveta Key News

7 SWINE VACCINES PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Swine Vaccines Production Capacity and Value in Japan, Situation Analysis and Prediction, 2015-2026
  7.1.1 Japan Swine Vaccines Production Capacity, 2015-2026
  7.1.2 Japan Swine Vaccines Production 2015-2026
  7.1.3 Japan Swine Vaccines Production Value 2015-2026
7.2 Key Local Swine Vaccines Manufacturers in Japan
  7.2.1 Japan Key Local Swine Vaccines Manufacturers Production Capacity
  7.2.2 Japan Key Local Swine Vaccines Manufacturers Production
  7.2.3 Japan Key Local Swine Vaccines Manufacturers Production Value
  7.2.4 The Proportion of Swine Vaccines Production Sold in Japan and Sold Other Than Japan by Manufacturers
7.3 Swine Vaccines Export and Import in Japan
  7.3.1 Japan Swine Vaccines Export Market
  7.3.2 Japan Swine Vaccines Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Japan Swine Vaccines Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON SWINE VACCINES SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Swine Vaccines Distributors and Sales Agents in Japan

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Swine Vaccines in Japan
Table 2. Top Players in Japan, Ranking by Revenue (2019)
Table 3. Japan Swine Vaccines Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Japan Swine Vaccines Revenue Share by Companies, 2015-2020
Table 5. Japan Swine Vaccines Sales by Companies, (M Doses), 2015-2020
Table 6. Japan Swine Vaccines Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Swine Vaccines Price (2015-2020) (USD/K Doses)
Table 8. Japan Manufacturers Swine Vaccines Product Type
Table 9. List of Japan Tier 1 Swine Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Japan Tier 2 and Tier 3 Swine Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Swine Vaccines Revenue in Japan (US$, Mn), 2015-2020
Table 12. By Type - Swine Vaccines Revenue in Japan (US$, Mn), 2021-2026
Table 13. By Type - Swine Vaccines Sales in Japan (M Doses), 2015-2020
Table 14. By Type - Swine Vaccines Sales in Japan (M Doses), 2021-2026
Table 15. By Application - Swine Vaccines Revenue in Japan, (US$, Mn), 2015-2020
Table 16. By Application - Swine Vaccines Revenue in Japan, (US$, Mn), 2021-2026
Table 17. By Application - Swine Vaccines Sales in Japan, (M Doses), 2015-2020
Table 18. By Application - Swine Vaccines Sales in Japan, (M Doses), 2021-2026
Table 19. Merck Corporate Summary
Table 20. Merck Swine Vaccines Product Offerings
Table 21. Merck Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 22. Boehringer Ingelheim Corporate Summary
Table 23. Boehringer Ingelheim Swine Vaccines Product Offerings
Table 24. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 25. Jinyu Bio-Technology Corporate Summary
Table 26. Jinyu Bio-Technology Swine Vaccines Product Offerings
Table 27. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 28. CAHIC Corporate Summary
Table 29. CAHIC Swine Vaccines Product Offerings
Table 30. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 31. Tecon Corporate Summary
Table 32. Tecon Swine Vaccines Product Offerings
Table 33. Tecon Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 34. Zoetis Corporate Summary
Table 35. Zoetis Swine Vaccines Product Offerings
Table 36. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 37. Ceva Corporate Summary
Table 38. Ceva Swine Vaccines Product Offerings
Table 39. Ceva Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 40. Hile Bio Corporate Summary
Table 41. Hile Bio Swine Vaccines Product Offerings
Table 42. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 43. Chopper Biology Corporate Summary
Table 44. Chopper Biology Swine Vaccines Product Offerings
Table 45. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 46. WINSUN Corporate Summary
Table 47. WINSUN Swine Vaccines Product Offerings
Table 48. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 49. Hipra Corporate Summary
Table 50. Hipra Swine Vaccines Product Offerings
Table 51. Hipra Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 52. Ringpu Biology Corporate Summary
Table 53. Ringpu Biology Swine Vaccines Product Offerings
Table 54. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 55. ChengDu Tecbond Corporate Summary
Table 56. ChengDu Tecbond Swine Vaccines Product Offerings
Table 57. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 58. DHN Corporate Summary
Table 59. DHN Swine Vaccines Product Offerings
Table 60. DHN Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 61. CAVAC Corporate Summary
Table 62. CAVAC Swine Vaccines Product Offerings
Table 63. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 64. Virbac Corporate Summary
Table 65. Virbac Swine Vaccines Product Offerings
Table 66. Virbac Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 67. HVRI Corporate Summary
Table 68. HVRI Swine Vaccines Product Offerings
Table 69. HVRI Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 70. Bioveta Corporate Summary
Table 71. Bioveta Swine Vaccines Product Offerings
Table 72. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 73. Swine Vaccines Production Capacity (M Doses) of Local Manufacturers in Japan, 2015-2020
Table 74. Swine Vaccines Production (M Doses) of Local Manufacturers in Japan, 2015-2020
Table 75. Japan Swine Vaccines Production Market Share of Local Manufacturers, 2015-2020
Table 76. Swine Vaccines Production Value (US$, Mn) of Local Manufacturers in Japan, 2015-2020
Table 77. Japan Swine Vaccines Production Value Market Share of Local Manufacturers, 2015-2020
Table 78. The Percentage of Swine Vaccines Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 79. The Percentage of Swine Vaccines Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 80. Dangeguojia Swine Vaccines Sales (Consumption), Production, Export and Import, 2015-2020
Table 81. Raw Materials and Suppliers
Table 82. Swine Vaccines Downstream Clients in Japan
Table 83. Swine Vaccines Distributors and Sales Agents in Japan

LIST OF FIGURES

Figure 1. Swine Vaccines Segment by Type
Figure 2. Swine Vaccines Segment by Application
Figure 3. Dangeguojia Swine Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Swine Vaccines Market Size in Japan, (US$, Mn) & (M Doses): 2020 VS 2026
Figure 6. Japan Swine Vaccines Revenue, 2015-2026 (US$, Mn)
Figure 7. Swine Vaccines Sales in Japan: 2015-2026 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Swine Vaccines Revenue in 2019
Figure 9. By Type - Japan Swine Vaccines Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Japan Swine Vaccines Market Share, 2015-2020
Figure 11. By Type - Japan Swine Vaccines Market Share, 2020-2026
Figure 12. By Type - Japan Swine Vaccines Price (USD/K Doses), 2015-2026
Figure 13. By Application - Swine Vaccines Revenue in Japan (US$, Mn), 2020 & 2026
Figure 14. By Application - Japan Swine Vaccines Market Share, 2015-2020
Figure 15. By Application - Japan Swine Vaccines Market Share, 2020-2026
Figure 16. By Application -Japan Swine Vaccines Price (USD/K Doses), 2015-2026
Figure 17. Japan Swine Vaccines Production Capacity (M Doses), 2015-2026
Figure 18. Japan Swine Vaccines Actual Output (M Doses), 2015-2026
Figure 19. Japan Swine Vaccines Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Japan Swine Vaccines Export Destination, 2019
Figure 21. The Source of Imports of Japan Swine Vaccines, 2019
Figure 22. PEST Analysis for Japan Swine Vaccines Market in 2020
Figure 23. Swine Vaccines Market Opportunities & Trends in Japan
Figure 24. Swine Vaccines Market Drivers in Japan
Figure 25. Swine Vaccines Market Restraints in Japan
Figure 26. Swine Vaccines Industry Value Chain


More Publications